Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans

NCT ID: NCT01688154

Last Updated: 2013-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Grape seed proanthocyanidins have been reported to possess a hypotriglyceridemic effect after an acute or chronic consumption in rodents. In this study, we aimed to investigate the effects of an acute consumption of proanthocyanidins before a breakfast meal in humans. Moreover, the mechanisms implicated in the reduction of plasma triglycerides levels by grape seed proanthocyanidins in humans should be elucidated as well as its activity on vascular function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The intervention will consist in the administration of 2 capsules containing the grape seed proanthocyanidins extract or 2 empty capsules (placebo) just before breakfast, which will consist of 100g of white bread, 75g of salami, 50g of fatty cheese, 125g of yogurt (10% fat), 25ml of olive oil and water ad libitum. The nutritional composition of this meal is as follows: 1.200 Kcal of energy content, 15% of energy from proteins, 22% from carbohydrates and 63% from fat (35% saturated fat), and 120mg of cholesterol. Blood samples will be taken at point 0.5,1,2,3 and 6 hours after breakfast. Moreover, urine samples will be collected at time 0 and 6 hours.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Triglyceride Metabolism Cardiovascular Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Product 1

35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)

Group Type ACTIVE_COMPARATOR

35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)

Intervention Type DIETARY_SUPPLEMENT

Control product

2 empty capsules

Group Type PLACEBO_COMPARATOR

2 empty capsules

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)

Intervention Type DIETARY_SUPPLEMENT

2 empty capsules

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults between the ages of 20 and 40
* Signing the informed consent

Exclusion Criteria

* Body mass index (BMI) lower than 18.5 or greater than 27 Kg/m2
* Smokers
* Regular medication
* Consumption of medication during the last week
* Following a weight-loss diet
* Vegetarians
* Abnormal glucose levels
* Diabetes
* Cardiovascular disease
* Gastrointestinal disease
* Anemia
* Nuts allergy
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Rovira i Virgili

OTHER

Sponsor Role collaborator

Hospital Universitari Sant Joan de Reus

OTHER

Sponsor Role collaborator

Technological Centre of Nutrition and Health, Spain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rosa SolĂ , PhD

Role: PRINCIPAL_INVESTIGATOR

University Rovira i Virgili

Maria Cinta Bladé, PhD

Role: PRINCIPAL_INVESTIGATOR

University Rovira i Virgili

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CTNS

Reus, Tarragona, Spain

Site Status

Technological Center of Nutrition and Health (CTNS)

Reus, Tarragona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

306724

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.